The Behavioral Economics of Substance Use Disorders: Reinforcement Pathologies and Their Repair

被引：483

作者：

Bickel, Warren K. ^{[1
]}

Johnson, Matthew W. ^{[2
]}

Koffarnus, Mikhail N. ^{[1
]}

MacKillop, James ^{[3
]}

Murphy, James G. ^{[4
]}

机构：

[1] Virginia Tech, Carilion Res Inst, Roanoke, VA 24016 USA

[2] Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA

[3] Univ Georgia, Dept Psychol, Athens, GA 30602 USA

[4] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA

来源：

ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 10 | 2014年 / 10卷

关键词：

addiction; behavior economics; reinforcer pathology; elasticity of demand; discounting; treatment; OPIOID-DEPENDENT OUTPATIENTS; CIGARETTE-SMOKING STATUS; DELAY-DISCOUNTING TASK; SELF-ADMINISTERED COCAINE; RANDOMIZED CLINICAL-TRIAL; YOUNG-ADULT SMOKING; CONTINGENCY MANAGEMENT; ALCOHOL-USE; DRUG-USE; HYPOTHETICAL REWARDS;

D O I：

10.1146/annurev-clinpsy-032813-153724

中图分类号：

B849 [应用心理学];

学科分类号：

040203 ;

摘要：

The field of behavioral economics has made important inroads into the understanding of substance use disorders through the concept of reinforcer pathology. Reinforcer pathology refers to the joint effects of (a) the persistently high valuation of a reinforcer, broadly defined to include tangible commodities and experiences, and/or (b) the excessive preference for the immediate acquisition or consumption of a commodity despite long-term negative outcomes. From this perspective, reinforcer pathology results from the recursive interactions of endogenous person-level variables and exogenous environment-level factors. The current review describes the basic principles of behavioral economics that are central to reinforcer pathology, the processes that engender reinforcer pathology, and the approaches and procedures that can repair reinforcement pathologies. The overall goal of this review is to present a new understanding of substance use disorders as viewed by recent advances in behavioral economics.

引用

页码：641 / 677

页数：37

共 267 条

[41] NICOTINE FADING, BEHAVIORAL CONTRACTING, AND EXTENDED TREATMENT - EFFECTS ON SMOKING CESSATION [J].

BOWERS, TG ;

WINETT, RA ;

FREDERIKSEN, LW .

ADDICTIVE BEHAVIORS, 1987, 12 (02) :181-184

[42] Social Discounting and Cigarette Smoking During Pregnancy [J].

Bradstreet, Matthew P. ;

Higgins, Stephen T. ;

Heil, Sarah H. ;

Badger, Gary J. ;

Skelly, Joan M. ;

Lynch, Mary Ellen ;

Trayah, Molly C. .

JOURNAL OF BEHAVIORAL DECISION MAKING, 2012, 25 (05) :502-511

[43] Understanding Naltrexone Mechanism of Action and Pharmacogenetics in Asian Americans via Behavioral Economics: A Preliminary Study [J].

Bujarski, Spencer ;

MacKillop, James ;

Ray, Lara A. .

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2012, 20 (03) :181-190

[44] Neural systems implicated in delayed and probabilistic reinforcement [J].

Cardinal, Rudolf N. .

NEURAL NETWORKS, 2006, 19 (08) :1277-1301

[45]

Carr Katelyn A, 2011, Curr Drug Abuse Rev, V4, P190

[46] Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less [J].

Carroll, Kathleen M. ;

Nich, Charla ;

LaPaglia, Donna M. ;

Peters, Erica N. ;

Easton, Caroline J. ;

Petry, Nancy M. .

ADDICTION, 2012, 107 (09) :1650-1659

[47] Modeling risk factors for nicotine and other drug abuse in the preclinical laboratory [J].

Carroll, Marilyn E. ;

Anker, Justin J. ;

Perry, Jennifer L. .

DRUG AND ALCOHOL DEPENDENCE, 2009, 104 :S70-S78

[48] Tobacco taxes as a tobacco control strategy [J].

Chaloupka, Frank J. ;

Yurekli, Ayda ;

Fong, Geoffrey T. .

TOBACCO CONTROL, 2012, 21 (02) :172-180

[49] Isolating behavioural economic indices of demand in relation to nicotine dependence [J].

Chase, Henry W. ;

MacKillop, James ;

Hogarth, Lee .

PSYCHOPHARMACOLOGY, 2013, 226 (02) :371-380

[50] Temporal Discounting in Heroin-Dependent Patients: No Sign Effect, Weaker Magnitude Effect, and the Relationship With Inhibitory Control [J].

Cheng, Jiuqing ;

Lu, Yanhong ;

Han, Xiaodong ;

Gonzalez-Vallejo, Claudia ;

Sui, Nan .

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2012, 20 (05) :400-409

← 1 2 3 4 5 6 7 8 9 10 →